Fisher & Paykel Healthcare CFO sells shares for tax obligations

Lyndal Jane York, chief financial officer of Fisher & Paykel Healthcare Corporation Limited, disclosed the sale of 26,500 ordinary shares in three separate transactions between December 9 and December 11, 2025. These sales reduced her beneficial interest from 79,117 to 52,617 ordinary shares, held jointly with Alexander Eric York. The transactions were undertaken to cover tax obligations from the exercise of DLTVR instruments earlier this year.

The sales occurred at prices ranging from AUD $32.8200 to AUD $33.1303 per ordinary share. Specifically, 1,890 shares were sold on December 9, 2025, 8 shares on December 10, 2025, and 24,602 shares on December 11, 2025. Following these disposals, Ms. York retains other relevant interests, including 122,638 options to acquire ordinary shares and 74,216 performance share rights, both representing a beneficial interest.

The disclosure was made on December 15, 2025, by Marcus Driller, vice president corporate, on behalf of the company.